Continuously strengthen knowledge learning and strive to improve the level of business
Release time:
2020-08-14
Continuously Strengthen Knowledge Learning Strive to Improve Business Level
Group Company 2017 Innovation Expert Tianjin Jianfeng Natural Products Company Sun Huageng
In the past year, I have conscientiously performed my duties as an enterprise scientific research worker, actively explored ideas and innovated working methods, work hard to learn business skills, pay attention to the accumulation of relevant policies and regulations, understand and grasp the development trend of the industry, and strive to refine the products and work in detail. In
2017 , we developed a project to conduct in-depth research and analysis on the problems in the production process of ginseng, apple, grape seed and other products. Through comparative experiments, we grasped the key factors affecting product quality, and fine-tuned the process parameters periodically through small-scale, pilot-scale and trial production, so as to significantly improve the mass production quality of the above products; mulberry, European bilberry and cranberry and other products have completed the trial production and expansion, and have made breakthroughs in the control of important indicators such as pesticide residues and plasticizers. The detection and identification methods of cranberry raw materials and their extracts have been developed and established, and the central control of mulberry extraction has been increased, which makes full technical preparation for the industrialization research of anthocyanin series products.
In terms of management, our department implements the product manager responsibility system to comprehensively cultivate and train the research, collaboration and crisis management capabilities of R & D personnel. New and old employees learn from each other and grow together, and have made certain progress and achievements in their own fields. Scientific researchers give full play to their professional and technical advantages, track, coordinate and guide, improve all production links of the company's products on sale, solve urgent problems in each production link in a timely manner, and ensure the normal operation of the production system from the technical level.
We earnestly do a good job of technical support, assist the salesman and QA personnel to answer customer questions, meet customer demands and maintain good customer relations. Assist the production department in scheduling each product to ensure the smooth completion of each product sales order; Accompany the purchasing personnel to visit the suppliers of raw materials and extracts to understand the current situation of technology and equipment development in the industry, learn from each other's strong points and promote the enterprise's own technological innovation. The achievements and honors of
2017 will eventually become the past. The challenging 2018 will inspire people to forge ahead. As a middle-level manager of the enterprise, I will strictly require myself with higher standards, continuously strengthen personal cultivation and professional knowledge learning, strive to improve the professional level, learn from each other's strong points, work hard, and strive to do the work better. I will give full play to the role of exemplary leadership, always maintain a good spirit and full of enthusiasm for work, wholeheartedly into the work, for the development of the company to contribute their own strength. (According to Sun Huageng's speech at the group company's summary commendation meeting)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31